Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$275.23-3.20 (-1.15%)
Delayed quote: Sep 4, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 4, 2026, 4:00 PM EDT
Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow (FCF) is $18.71B as of the fiscal period ended Sunday, June 28, 2026. It is above its 12-month average by 2.00% ($18.34B).
Reported quarterly free cash flow; no daily interpolation.
Free Cash Flow growth vs the same quarter one year earlier, last 40 quarters.
FREE CASH FLOW (FCF)
$18.71B
FREE CASH FLOW (FCF) AVG TTM
$18.34B
FREE CASH FLOW (FCF) AVG 3Y
$18.65B
FREE CASH FLOW (FCF) AVG 5Y
$18.82B
FREE CASH FLOW (FCF) AVG 10Y
$18.57B
FREE CASH FLOW (FCF) AVG 15Y
$16.75B
FREE CASH FLOW (FCF) AVG 20Y
$15.71B
CURRENT VS TTM AVG
+2.00%
CURRENT VS 3Y AVG
+0.33%
CURRENT VS 5Y AVG
-0.61%
CURRENT VS 10Y AVG
+0.77%
CURRENT VS 15Y AVG
+11.67%
CURRENT VS 20Y AVG
+19.11%
Free Cash Flow (TTM)
$18.71B
FCF Yield
2.79%
Price/FCF
35.9
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2026-06-28 | $18.71B |
| 2026-03-29 | $17.80B |
| 2025-12-28 | $19.71B |
| 2025-09-28 | $19.08B |
| 2025-06-29 | $16.41B |
| 2025-03-30 | $18.59B |
| 2024-12-29 | $18.06B |
| 2024-09-29 | $19.50B |
| 2024-06-30 | $20.30B |
| 2024-03-31 | $18.70B |
| 2023-12-31 | $18.25B |
| 2023-10-01 | $15.74B |
| 2023-07-02 | $14.55B |
| 2023-04-02 | $16.21B |
| 2022-12-31 | $17.18B |
| 2022-10-02 | $17.74B |
| 2022-07-03 | $19.95B |
| 2022-04-03 | $19.73B |
| 2021-12-31 | $19.76B |
| 2021-10-03 | $22.46B |
| 2021-07-04 | $22.56B |
| 2021-04-04 | $20.85B |
| 2020-12-31 | $20.19B |
| 2020-09-27 | $18.31B |
| 2020-06-28 | $17.44B |
| 2020-03-29 | $19.76B |
| 2019-12-31 | $19.92B |
| 2019-09-29 | $19.71B |
| 2019-06-30 | $18.38B |
| 2019-03-31 | $18.47B |
| 2018-12-31 | $18.53B |
| 2018-09-30 | $18.47B |
| 2018-07-01 | $18.49B |
| 2018-04-01 | $18.37B |
| 2017-12-31 | $17.78B |
| 2017-10-01 | $18.47B |
| 2017-07-02 | $17.62B |
| 2017-04-02 | $16.77B |
| 2016-12-31 | $15.54B |
| 2016-10-02 | $13.70B |
| 2016-07-03 | $14.41B |
| 2016-04-03 | $14.61B |
| 2015-12-31 | $15.82B |
| 2015-09-27 | $14.97B |
| 2015-06-28 | $13.54B |
| 2015-03-29 | $13.79B |
| 2014-12-31 | $14.76B |
| 2014-09-28 | $14.60B |
| 2014-06-29 | $15.83B |
| 2014-03-30 | $15.42B |
| 2013-12-31 | $13.82B |
| 2013-09-29 | $13.33B |
| 2013-06-30 | $12.01B |
| 2013-03-31 | $11.86B |
| 2012-12-31 | $12.46B |
| 2012-09-30 | $12.56B |
| 2012-07-01 | $12.66B |
| 2012-04-01 | $11.82B |
| 2011-12-31 | $11.40B |
| 2011-10-02 | $11.95B |
| 2011-07-03 | $12.54B |
| 2011-04-03 | $12.59B |
| 2010-12-31 | $14.00B |
| 2010-10-03 | $15.58B |
| 2010-07-04 | $15.65B |
| 2010-04-04 | $15.11B |
| 2009-12-31 | $14.21B |
| 2009-09-27 | $12.67B |
| 2009-06-28 | $12.18B |
| 2009-03-29 | $11.56B |
| 2008-12-31 | $11.91B |
| 2008-09-28 | $11.82B |
| 2008-06-29 | $11.21B |
| 2008-03-30 | $11.32B |
| 2007-12-31 | $11.94B |
| 2007-09-30 | $12.40B |
| 2007-07-01 | $12.35B |
| 2007-04-01 | $11.83B |
| 2006-12-31 | $11.51B |
| 2006-10-01 | $10.28B |
| 2006-07-02 | $10.23B |
| 2006-04-02 | $10.02B |
| 2005-12-31 | $9.24B |
| 2005-10-02 | $8.63B |
| 2005-07-03 | $8.70B |
| 2005-04-03 | $8.85B |
| 2004-12-31 | $8.96B |
| 2004-09-26 | $10.29B |
| 2004-06-27 | $9.62B |
| 2004-03-28 | $9.07B |
| 2003-12-31 | $8.33B |
| 2003-09-28 | $6.90B |
| 2003-06-29 | $6.17B |